The Usual Suspects: Verdict Not Guilty?

Arthritis and Rheumatism

Volumn 48, Issue 12, 2003, Pages 3304-3307

  Tortorella, Micky D ^a,b   Malfait, Anne Marie ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE SYNTHASE; STROMELYSIN;

ARTHROPATHY; CARTILAGINOUS TISSUE; CHONDROPATHY; CHRONIC DISEASE; DISEASE MODEL; EDITORIAL; HUMAN; OSTEOARTHRITIS; OSTEOSCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CASPASE 1; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; OSTEOARTHRITIS;

EID: 0348111255     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11356     Document Type: Editorial

References (16)

1. Clements KM, Price JS, Chambers MG, Visco DM, Poole AR, Mason RM. Gene deletion of either interleukin-1β, interleukin-1B-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum 2003;48:3452-63.
2. Tortorella MD, Pratta M, Liu RQ, Austin J, Ross OH, Abbaszade I, et al. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 2000;275:18566-73.
3. Ilic MZ, Robinson HC, Handley CJ. Characterization of aggrecan retained and lost from the extracellular matrix of articular cartilage. J Biol Chem 1998;273:17451-8.
4. Tortorella MD, Malfait AM, Decicco C, Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2001;9:539-52.
5. Malfait AM, Liu R-Q, Ijiri K, Setsuro K, Tortorella M. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 2002;277:22201-8.
6. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid: evidence for the involvement in osteoarthritis of a novel protease which cleaves the Glu373-Ala374 bond of the interglobular domain. J Clin Invest 1992;89:1512-6.
7. Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, et al. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000;43:673-82.
8. Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 2002;46:2087-94.
9. Little CB, Hughes CE, Curtis CL, Jones SA, Caterson B, Flannery CR. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage. Arthritis Rheum 2002;46:124-9.
10. Hollander AP, Dieppe PA, Atkins RM, Elson CJ. Hypothesis: cartilage catabolic cofactors in human arthritis. J Rheumatol 1993;20:223-4.
11. Sztrolovics R, White RJ, Roughley PJ, Mort JS. The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism. Biochem J 2002;362:465-72.
12. Pratta MA, Yao W, Decicco C, Tortorella MD, Liu RQ, Copeland RA, et al. Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem. In press.
13. Curtis CL, Rees SG, Little CB, Flannery CR, Hughes CE, Wilson C, et al. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum 2002;46:1544-53.
14. Homandberg G. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci 1999;4: D713-30.
15. Stanton H, Ung L, Fosang A. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem J 2002;364:181-90.
16. Yasuda T, Poole AR. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 2002;46:138-48.